首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Merits of HPLC-based method over spectrophotometric method for assessing the kinetics and inhibition of mammalian adenosine deaminase
【24h】

Merits of HPLC-based method over spectrophotometric method for assessing the kinetics and inhibition of mammalian adenosine deaminase

机译:基于HPLC的方法优于分光光度法评估哺乳动物腺苷脱氨酶动力学和抑制作用的优点

获取原文
获取原文并翻译 | 示例
           

摘要

Measurement of adenosine deaminase (ADA) activity using spectrophotometric method presents problem, regarding the quantitative estimation of the substrate degradation and product formation, due to the closely apposed lamda(max) of the substrates, product and the inhibitor. The feasibility of applying reverse-phase HPLC technique, for studying adenosine deaminase-catalyzed reaction product and inhibition study was examined. We have drawn a comparison between the RPLC-based method over the corresponding spectrophotometric method. A gradient elution pattern was used to separate substrate (adenosine and deoxyadenosine), product (inosine and deoxymosine) and standard adenosine deaminase inhibitor (erythro-9-(3-nonyl-rho-aminobenzyl)-adenine) in the HPLC method. The product formation was quantitated by monitoring the absorbance at 260 nm with the progress of time. The limit of detection as well as the limit of quantification of the respective enzymatic product were found to be in nano molar (nM) range in the HPLC method. This study was also extended to monitor adenosine deaminase activity in different cancer cells of hematological origin. The HPLC-based method is found to be suitable for the quantitative estimation of adenosine deaminase-catalyzed reaction product and for studying inhibition mechanism of different inhibitors. The HPLC-based method has specific advantages over the spectrophotometric method. Moreover, the concentration of different nucleotides in cell lysate and body fluid can be measured using this HPLC method. (c) 2005 Elsevier B.V. All rights reserved.
机译:使用分光光度法测量腺苷脱氨酶(ADA)的活性,由于底物,产物和抑制剂的lamda(max)紧密相关,对底物降解和产物形成的定量估计存在问题。考察了应用反相高效液相色谱技术研究腺苷脱氨酶催化反应产物和抑制作用的可行性。我们在基于RPLC的方法与相应的分光光度法之间进行了比较。在HPLC方法中,使用梯度洗脱模式分离底物(腺苷和脱氧腺苷),产物(肌苷和脱氧mosine)和标准腺苷脱氨酶抑制剂(erythro-9-(3-壬基-rho-氨基苄基)-腺嘌呤)。随着时间的流逝,通过监测260nm处的吸光度来定量产物的形成。在HPLC方法中发现各酶产物的检出限和定量限在纳摩尔(nM)范围内。这项研究还扩展到监测血液学来源的不同癌细胞中的腺苷脱氨酶活性。发现基于HPLC的方法适用于定量评估腺苷脱氨酶催化的反应产物以及研究不同抑制剂的抑制机理。相对于分光光度法,基于HPLC的方法具有特定的优势。而且,可以使用该HPLC方法测量细胞裂解液和体液中不同核苷酸的浓度。 (c)2005 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号